InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,792.80
(
0.00%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.28
(
-0.38%
)
Bitcoin
62,950.00
(
3.57%
)
Post# of 252595
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

WorstLuck

Send PM Follow Ignore
Followers 11
Posts 1047
Boards Moderated 0
Alias Born 02/23/2010

WorstLuck

Re: None

Tuesday, 08/07/2018 10:28:18 AM

Tuesday, August 07, 2018 10:28:18 AM

Post# of 252595
ABBV, ENTA, GILD etc

https://www.bloomberg.com/news/articles/2018-08-07/express-scripts-to-drop-big-sellers-from-abbvie-gilead-in-2019

Express Scripts Holding Co. said it will drop 48 drugs next year from its closely watched lineup of covered therapies, including Gilead Sciences Inc.’s HIV treatment Atripla and AbbVie Inc.’s hot-selling Mavyret medicine for hepatitis C.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up